ASGCT and ISCT abstracts highlight the Company’s progress with gene circuit-engineered allogeneic CAR-NK cell therapy pipeline ASGCT and ISCT abstracts highlight the Company’s progress with gene circuit-engineered allogeneic CAR-NK cell therapy pipeline

Read the rest here:
Senti Bio to Present Data from CAR-NK Cell Oncology Pipeline at Upcoming Scientific Conferences

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh